DeoxyArbutin: a novel reversible tyrosinase inhibitor with effective in vivo skin lightening potency.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMID 16026582)

Published in Exp Dermatol on August 01, 2005

Authors

Raymond E Boissy1, Marty Visscher, Mitchell A DeLong

Author Affiliations

1: Department of Dermatology, University of Cincinnati College of Medicine, Cincinnati, OH 45267-0592, USA. boissyre@ucmail.uc.edu

Articles citing this

Topical treatment of melasma. Indian J Dermatol (2009) 1.25

Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. J Clin Aesthet Dermatol (2010) 1.13

Skin ageing: natural weapons and strategies. Evid Based Complement Alternat Med (2013) 1.02

Mechanisms regulating skin pigmentation: the rise and fall of complexion coloration. Int J Mol Sci (2009) 0.98

A clinical study of melasma and a comparison of the therapeutic effect of certain currently available topical modalities for its treatment. Indian J Dermatol (2013) 0.93

Study on the stability of deoxyArbutin in an anhydrous emulsion system. Int J Mol Sci (2011) 0.87

Determination of the thermodegradation of deoxyArbutin in aqueous solution by high performance liquid chromatography. Int J Mol Sci (2010) 0.84

Cosmeceuticals for Hyperpigmentation: What is Available? J Cutan Aesthet Surg (2013) 0.83

[6]-Shogaol inhibits melanogenesis in B16 mouse melanoma cells through activation of the ERK pathway. Acta Pharmacol Sin (2012) 0.82

In vitro techniques to assess the proficiency of skin care cosmetic formulations. Pharmacogn Rev (2013) 0.82

Large-Scale Recombinant Expression and Purification of Human Tyrosinase Suitable for Structural Studies. PLoS One (2016) 0.81

The biochemical and cellular basis for nutraceutical strategies to attenuate neurodegeneration in Parkinson's disease. Int J Mol Sci (2011) 0.80

The Inhibitory Effect of Phytoclear-EL1 on Melanogenesis. Ann Dermatol (2009) 0.75

Deoxyarbutin Possesses a Potent Skin-Lightening Capacity with No Discernible Cytotoxicity against Melanosomes. PLoS One (2016) 0.75

Deoxyarbutin displays antitumour activity against melanoma in vitro and in vivo through a p38-mediated mitochondria associated apoptotic pathway. Sci Rep (2017) 0.75